Oakworth Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Oakworth Capital's RGEN Position: Q2 2026 in Review
Oakworth Capital held its Repligen (RGEN) position steady in Q2 2026 at 250 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #523.
Oakworth Capital first reported a position in RGEN in Q1 2016 and has held it in 31 quarters since. The position peaked at $83K in Q3 2018. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Oakworth Capital held 250 shares of Repligen worth $34.1K as of Q2 2026.
- Oakworth Capital left its Repligen share count unchanged in Q2 2026.
- Repligen made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #523 holding.
- Oakworth Capital first reported a position in Repligen in Q1 2016 and has held it in 31 quarters since.
- Oakworth Capital's Repligen position peaked at $83K in Q3 2018.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.